Pharma Journalist -

BPI Europe Summit, THE Bioprocessing event, bringing together key players from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety…
Read More...

AstraZeneca asserted that the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) has voted in favor of a renewed recommendation for the…
Read More...

NaviGate Cardiac Structures asserted that its catheter-guided GATE valved-stent bioprosthesis became the first Canadian orthotopic valve replacement to treat severe tricuspid…
Read More...

Clovis Oncology claimed an update to the ongoing regulatory review for the Marketing Authorization Application (MAA) for Rucaparib tablets as monotherapy for the treatment of advanced…
Read More...

Merck and Viralytics claimed that the companies have ventured into a definitive agreement that enumerates Merck's acquisition of Viralytics emphasizing on oncolytic immunotherapy…
Read More...

Celgene Corporation asserted that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender…
Read More...

McKesson Specialty Health oncology and complex care pharmacy services company has been finalized by the Janssen Pharmaceutical Companies of Johnson & Johnson which is considered the…
Read More...

Vertex Pharmaceuticals affirmed initiating the first Phase 3 study of VX-659,  tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis…
Read More...

U.S FDA had asserted the destruction and recall of large volume of kratom-containing dietary supplements that is ideally manufactured and distributed nationwide under the Brand names…
Read More...

Evidenced-based dual diagnosis treatment facility, Chiron Recovery executed a MAT program for the treatment of opioid addiction. Addiction is a chronic disease and just like other…
Read More...